Marcela B. Mansur
Contact information
marcela.bragamansur@paediatrics.ox.ac.uk
+44 (0) 1865 222 419
https://orcid.org/0000-0002-4854-2031
University of Oxford Department of Paediatrics Level 2, Children's Hospital, John Radcliffe Oxford OX3 9DU
Research groups
Collaborators
-
Irene Roberts
Emeritus Professor of Paediatric Haematology
-
Adam Mead
Professor of Haematology
Marcela B. Mansur
PhD
Leukaemia UK John Goldman Research Fellow
Unravelling the cell-of-origin in MLL-AF4+ ALL
Biography & Research Focus
Graduated in Biomedicine (2005) at Universidade Federal do Estado do Rio de Janeiro (UNIRIO), MSc (2008) and PhD (2011) degrees in Oncology both at Instituto Nacional de Câncer (INCA), Post-doctoral training: INCA, Rio de Janeiro - Brazil (2011-2012) & The Institute of Cancer Research (ICR), London - UK in Professor Sir Mel Greaves' team (2012-2015). I was a Visiting Young Investigator in the Research Centre, INCA (2015-2021), before joining the Childhood Leukaemia Research Group, Department of Paediatrics, University of Oxford as a Leukaemia UK John Goldman Research Fellow.
My research experience to date has focused on genomic profiling of infant and childhood T-ALL. After my PhD, I successfully applied for an EHA Partner Fellowship which allowed me to train in Prof Greaves’ team. This was a unique and very fruitful experience, and as part of the EHA award, I returned to Brazil for some years to share the expertise acquired and mentor other younger researchers.
Now, back in the UK as a John Goldman Research Fellow in the Childhood Leukaemia Research Group, I aim to gain independence by performing an innovative project focused on unravelling the cell-of-origin in MLL-AF4+ acute lymphoblastic leukaemia at a single-cell level. This project will systematically characterise MLL-AF4+ ALL at a single-cell level in infants, children and adults using the same platforms (TARGET-seq, i.e. genotyping and transcriptome analysis of single-cells, in collaboration with Prof Adam Mead). This will answer a long-held question in the field about the cell-of-origin of MLL-r ALL and whether the leukaemia initiating translocation can be detected in non-B lymphoid, upstream haematopoietic stem and progenitor cells. This research project will provide fundamental insight into ALL pathogenesis and may pinpoint key vulnerabilities of treatment-resistant ALL, which can be exploited for targeted drug discovery and/or immunotherapeutic approaches.
Recent publications
-
The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia
Braga Mansur M. et al, (2021), Cancer Medicine
-
Implementation of a pharmacogenomic program in a Brazilian public institution
Suarez-Kurtz G. et al, (2020), Pharmacogenomics, 21, 549 - 557
-
FLT3 overexpression in acute leukaemias: New insights into the search for molecular mechanisms.
Poubel CP. et al, (2019), Biochimica et biophysica acta. Reviews on cancer, 1872, 80 - 88
-
IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia.
Lopes BA. et al, (2019), Translational oncology, 12, 726 - 732
-
CRLF2 expression associates with ICN1 stabilization in T-cell acute lymphoblastic leukemia.
Maciel ALT. et al, (2019), Genes, chromosomes & cancer, 58, 396 - 401